Prophylactic Effect of Lipoic Acid against Doxorubicin-Induced Biochemical and Histological Alterations in Rat Kidney

Doxorubicin (DOX), an extensively used chemotherapeutic agent, faces restrictions due to its nephrotoxic effects. The study explores the therapeutic usefulness of alpha-Lipoic Acid (LA) on DOX-mediated biochemical and pathological changes. The study assigned healthy adult male Wistar rats to four groups. Rats that received an intravenous (i.v.) administration of a single dose of DOX (7.5 mg/kg body weight) through the tail vein served as the pathology group. Rats administered LA (75 mg/kg body weight) intraperitoneally (i.p.), 24 h before the administration of DOX, served as the treatment group. DOX-induced nephrotoxicity was evident by increased excretion of urinary constituents [urea, phosphorus, protein] and urinary enzymes [alkaline phosphatase (ALP), lactate dehydrogenase (LDH), N-acetyl-?-D-glucosaminidase (NAG), ?-glutamyltransferase (GGT), ?-glucuronidase (GUSB)] with a concomitant decrease in renal enzyme activities [ALP, LDH, NAG, and cathepsin D (CD)]. Histopathological examinations of the kidneys of DOX-administered rats revealed tubular dilation in the collecting tubules and tubular epithelial damage. LA treatment before DOX administration significantly conserved the levels/activities of urinary constituents, urinary enzymes, and renal enzymes, and reduced the severity of renal lesions incurred due to DOX. Major Findings: The study concludes that LA�s potent antioxidant properties, which scavenge Reactive Oxygen Species (ROS) and bolster cellular defence systems, make it a highly effective agent in preventing DOX-induced nephrotoxicity. It proposes LA as a promising adjunct therapy in cancer chemotherapy to reduce painful side effects.

View article page

Download PDF